BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19816688)

  • 1. Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?
    Bay-Jensen AC; Hoegh-Madsen S; Dam E; Henriksen K; Sondergaard BC; Pastoureau P; Qvist P; Karsdal MA
    Rheumatol Int; 2010 Feb; 30(4):435-42. PubMed ID: 19816688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis.
    Yu D; Xu J; Liu F; Wang X; Mao Y; Zhu Z
    Clin Exp Rheumatol; 2016; 34(5):929-934. PubMed ID: 27606839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modification: promising targets and impediments to success.
    Matthews GL
    Rheum Dis Clin North Am; 2013 Feb; 39(1):177-87. PubMed ID: 23312415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticytokine therapy for osteoarthritis: evidence to date.
    Malemud CJ
    Drugs Aging; 2010 Feb; 27(2):95-115. PubMed ID: 20104937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondroprotective drugs in degenerative joint diseases.
    Verbruggen G
    Rheumatology (Oxford); 2006 Feb; 45(2):129-38. PubMed ID: 16278282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols.
    Ansari MY; Ahmad N; Haqqi TM
    Biomed Pharmacother; 2020 Sep; 129():110452. PubMed ID: 32768946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential wear patterns of the articular cartilage of the thumb carpometacarpal joint in osteoarthritis.
    Koff MF; Ugwonali OF; Strauch RJ; Rosenwasser MP; Ateshian GA; Mow VC
    J Hand Surg Am; 2003 Jul; 28(4):597-604. PubMed ID: 12877846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OA in 2011: Age-related OA--a concept emerging from infancy?
    Aigner T; Richter W
    Nat Rev Rheumatol; 2012 Jan; 8(2):70-2. PubMed ID: 22231238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in osteoarthritis and cartilage biology.
    Poulet B; Staines KA
    Curr Opin Pharmacol; 2016 Jun; 28():8-13. PubMed ID: 26921602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis.
    Ashraf S; Mapp PI; Walsh DA
    Arthritis Rheum; 2011 Sep; 63(9):2700-10. PubMed ID: 21538326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis.
    Schroeppel JP; Crist JD; Anderson HC; Wang J
    Histol Histopathol; 2011 Mar; 26(3):377-94. PubMed ID: 21210351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bone in osteoarthritis pathogenesis.
    Goldring SR
    Med Clin North Am; 2009 Jan; 93(1):25-35, xv. PubMed ID: 19059019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?
    Brandt KD
    Rheum Dis Clin North Am; 1993 Feb; 19(1):29-44. PubMed ID: 8356260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cartilage degradation and suppression of PGE
    Akhtar N; Khan NM; Ashruf OS; Haqqi TM
    Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoarthritis: histology and pathogenesis.
    Sulzbacher I
    Wien Med Wochenschr; 2013 May; 163(9-10):212-9. PubMed ID: 23263638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.
    TenBroek EM; Yunker L; Nies MF; Bendele AM
    Arthritis Res Ther; 2016 Jan; 18():24. PubMed ID: 26794830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs?
    Brandt KD
    Rheum Dis Clin North Am; 1993 Aug; 19(3):697-712. PubMed ID: 8210582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of joint structures to inactivity and to reloading after immobilization.
    Brandt KD
    Arthritis Rheum; 2003 Apr; 49(2):267-71. PubMed ID: 12687522
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale for the potential use of calcitonin in osteoarthritis.
    Manicourt DH; Devogelaer JP; Azria M; Silverman S
    J Musculoskelet Neuronal Interact; 2005; 5(3):285-93. PubMed ID: 16172519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroprotective/structure-modifying drugs: a neverending story.
    Henrotin Y
    Reumatismo; 2006; 58 Spec No.1():15-6. PubMed ID: 23631055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.